{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:25Z","timestamp":1790155705641,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180437","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T13:43:15Z","timestamp":1500990195000},"page":"e0180437","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6080-9555","authenticated-orcid":true,"given":"Daniel P.","family":"Franzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bonani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dormond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A.","family":"Krayenbuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Barbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"issue":"9647","key":"ref1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"YA Zarate","year":"2008","journal-title":"Lancet"},{"issue":"52","key":"ref2","doi-asserted-by":"crossref","first-page":"e2413","DOI":"10.1097\/MD.0000000000002413","article-title":"Prevalence and Risk Factors of Sleep Disordered Breathing in Fabry disease: A Prospective Cohort Study","volume":"94","author":"D Franzen","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejim.2013.05.003","article-title":"Pulmonary involvement in Fabry disease: overview and perspectives","volume":"24","author":"D Franzen","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"suppl","key":"ref4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF01825509","article-title":"Zur Klinik und Aetiologie des Angiokeratoma","volume":"123","author":"J Fabry","year":"1916","journal-title":"Arch Dermatol"},{"key":"ref5","author":"CC Sweeley","year":"1996"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS\u2014Fabry Outcome Survey","volume":"46","author":"A Mehta","year":"2009","journal-title":"J Med Genet"},{"issue":"6","key":"ref7","first-page":"681","article-title":"Fabry's disease. A correlative clinical, morphologic, and biochemical study","volume":"18","author":"JD Bagdade","year":"1968","journal-title":"Lab Invest"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2559.1991.tb01510.x","article-title":"Pulmonary vasculature in Fabry's disease","volume":"19","author":"P Smith","year":"1991","journal-title":"Histopathology"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0002-9343(80)90224-7","article-title":"Chronic airflow obstruction in Fabry's disease","volume":"68","author":"DM Rosenberg","year":"1980","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"ref10","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1007\/s10545-008-0930-x","article-title":"Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage","volume":"31","author":"RY Wang","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/thorax.55.8.720","article-title":"Induced sputum examination: diagnosis of pulmonary involvement in Fabry's disease","volume":"55","author":"MM Kelly","year":"2000","journal-title":"Thorax"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0002-9343(72)90194-5","article-title":"Pulmonary involvement in Fabry's disease: a reappraisal follow-up of a San Diego kindred and review of literature","volume":"53","author":"EE Bartimmo Jr.","year":"1972","journal-title":"Am J Med"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2143\/AC.65.2.2047052","article-title":"Cardiopulmonary involvement in Fabry's disease","volume":"65","author":"JW Koskenvuo","year":"2010","journal-title":"Acta Cardiol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajmg.a.31600","article-title":"Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy","volume":"143","author":"W Kim","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"N Macintyre","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary","volume":"163","author":"RA Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"BR Celli","year":"2004","journal-title":"Eur Respir J"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"C Whybra","year":"2004","journal-title":"Clin Genet"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/ajrccm.155.3.9116979","article-title":"Pulmonary involvement in Fabry disease","volume":"155","author":"LK Brown","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1183\/09031936.00004110","article-title":"Prevalence of airflow obstruction in smokers and never-smokers in Switzerland","volume":"36","author":"PO Bridevaux","year":"2010","journal-title":"Eur Respir J"},{"issue":"9589","key":"ref22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study","volume":"370","author":"AS Buist","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000087675","article-title":"Cardiopulmonary exercise testing in Fabry disease","volume":"72","author":"G Bierer","year":"2005","journal-title":"Respiration"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10545-007-0616-9","article-title":"Natural history of the respiratory involvement in Anderson-Fabry disease","volume":"30","author":"S Magage","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1741-7015-8-84","article-title":"Systematic review of the evidence relating FEV1 decline to giving up smoking","volume":"8","author":"PN Lee","year":"2010","journal-title":"BMC Med"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1345","article-title":"Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment","volume":"146","author":"X Xu","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/COPD.S27480","article-title":"Lung function decline in COPD","volume":"7","author":"C Tantucci","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref28","article-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"JD Aubert","year":"2006"},{"issue":"9706","key":"ref29","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data","volume":"374","author":"A Mehta","year":"2009","journal-title":"Lancet"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"R Schiffmann","year":"2001","journal-title":"Jama"},{"key":"ref31","first-page":"Cd006663","article-title":"Enzyme replacement therapy for Anderson-Fabry disease","volume":"7","author":"R El Dib","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference","volume":"91","author":"R Schiffmann","year":"2017","journal-title":"Kidney Int"},{"key":"ref33","first-page":"105","article-title":"Spirometric abnormalities in patients with Fabry disease and effect of enzyme replacement therapy","volume":"447","author":"F Barbey","year":"2005","journal-title":"Acta Paediatr"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1378\/chest.06-1349","article-title":"Spirometric criteria for airway obstruction: Use percentage of FEV1\/FVC ratio below the fifth percentile, not < 70%","volume":"131","author":"JE Hansen","year":"2007","journal-title":"Chest"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1183\/09031936.00143209","article-title":"Reference values for lung function: past, present and future","volume":"36","author":"S Stanojevic","year":"2010","journal-title":"Eur Respir J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:53:29Z","timestamp":1540270409000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180437"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180437","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]}}}